ODG
HUMA icon

O'Dell Group’s Humacyte HUMA Stock Holding History

O'Dell Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,500
Closed -$4.26K – 258
2023
Q4 		$4.26K Buy
+1,500
New +$3.85K ﹤0.01% 402
2023
Q3 		– Sell
-1,500
Closed -$4.29K – 249
2023
Q2 		$4.29K Buy
+1,500
New +$5.41K ﹤0.01% 398
2022
Q4 		– Sell
-1,500
Closed -$5K – 218
2022
Q3 		$5K Hold
1,500
– – ﹤0.01% 328
2022
Q2 		$5K Hold
1,500
– – ﹤0.01% 341
2022
Q1 		$11K Hold
1,500
– – ﹤0.01% 308
2021
Q4 		$11K Hold
1,500
– – ﹤0.01% 292
2021
Q3 		$17K Buy
+1,500
New +$17.2K 0.01% 249

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

O'Dell Group's HUMA Position: Q1 2024 in Review

O'Dell Group sold out of Humacyte (HUMA) in Q1 2024, closing a stake of 1,500 shares — an estimated $4.26K sold.

O'Dell Group first reported a position in HUMA in Q3 2021 and held it in 7 quarters. The position peaked at $17K in Q3 2021. 96 funds tracked by Wall St. Rank hold HUMA as of Q1 2024.

  • O'Dell Group reported no remaining Humacyte position as of Q1 2024 after selling out during the quarter.
  • O'Dell Group sold 1,500 Humacyte shares in Q1 2024, an estimated $4.26K.
  • O'Dell Group first reported a position in Humacyte in Q3 2021 and held it in 7 quarters.
  • O'Dell Group's Humacyte position peaked at $17K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Humacyte as of Q1 2024.

Based on O'Dell Group's 13F filing for Q1 2024, filed 7 May 2024.